Yee L, Williams N, Wen P, Young D, Lester J, Johnson M, et al. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. Clin Cancer Res. 2007;13:246-52 pubmed
..Our data indicate that short-term rosiglitazone therapy in early-stage breast cancer patients leads to local and systemic effects on PPARgamma signaling that may be relevant to breast cancer. ..
Yee L, Agarwal D, Rosol T, Lehman A, Tian M, Hatton J, et al. The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. Mol Nutr Food Res. 2013;57:320-7 pubmed publisher
..This histologic change is associated with suppression of mammary epithelial cell proliferation and decreased COX-2 expression in mammary tissue. ..